» Articles » PMID: 15215108

Beneficial Influence of Platelets on Antibiotic Efficacy in an in Vitro Model of Staphylococcus Aureus-induced Endocarditis

Overview
Specialty Pharmacology
Date 2004 Jun 25
PMID 15215108
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets contribute to antimicrobial host defense against infective endocarditis (IE) by releasing platelet microbicidal proteins (PMPs). We investigated the influence of thrombin-stimulated human platelets on the evolution of simulated IE in the presence and absence of vancomycin or nafcillin. Staphylococcus aureus strains differing in intrinsic susceptibility to PMPs or antibiotics were studied: ISP479C (thrombin-induced PMP-1 [tPMP-1] susceptible; nafcillin and vancomycin susceptible), ISP479R (tPMP-1 resistant; nafcillin and vancomycin susceptible), and GISA-NJ (tPMP-1 intermediate-susceptible; vancomycin intermediate-susceptible). Platelets were introduced and thrombin activated within the in vitro IE model 30 min prior to inoculation with S. aureus. At 0 to 24 h postinoculation, bacterial densities in chamber fluid and simulated endocardial vegetations (SEVs) were quantified and compared among groups. Activated platelets alone, or in combination with antibiotics, inhibited the proliferation of ISP479C in chamber fluid or SEVs over the initial 4-h period (P < 0.05 versus controls). Moreover, nafcillin-containing regimens exerted inhibitory effects beyond 4 h against ISP479C in both model phases. By comparison, activated platelets inhibited GISA-NJ proliferation in SEVs but not in chamber fluid. The combination of platelets plus nafcillin or vancomycin significantly inhibited proliferation of the GISA-NJ strain in SEVs compared to the effect of platelets or antibiotics alone (P < 0.05). In contrast, platelets did not significantly alter the antistaphylococcal efficacies of nafcillin or vancomycin against ISP479R. These data support our hypothesis that a beneficial antimicrobial effect may result from the interaction among platelets, PMPs, and anti-infective agents against antibiotic-susceptible or -resistant staphylococci that exhibit a tPMP-1-susceptible or -intermediate-susceptible phenotype.

Citing Articles

Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review.

Ouyang H, Tang Y, Yang F, Ren X, Yang J, Cao H Front Endocrinol (Lausanne). 2024; 14:1256081.

PMID: 38169990 PMC: 10760804. DOI: 10.3389/fendo.2023.1256081.


Roles of MicroRNA-21 in Skin Wound Healing: A Comprehensive Review.

Xie J, Wu W, Zheng L, Lin X, Tai Y, Wang Y Front Pharmacol. 2022; 13:828627.

PMID: 35295323 PMC: 8919367. DOI: 10.3389/fphar.2022.828627.


Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro.

Gilbertie J, Schaer T, Schubert A, Jacob M, Menegatti S, Lavoie R J Orthop Res. 2020; 38(6):1365-1374.

PMID: 31922274 PMC: 8018705. DOI: 10.1002/jor.24584.


Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide.

Kohler C, Proctor R, Bayer A, Yeaman M, Lalk M, Engelmann S Antibiotics (Basel). 2019; 8(4).

PMID: 31569354 PMC: 6963496. DOI: 10.3390/antibiotics8040169.


Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds.

Li T, Ma Y, Wang M, Wang T, Wei J, Ren R Infect Drug Resist. 2019; 12:297-309.

PMID: 30774397 PMC: 6357877. DOI: 10.2147/IDR.S186651.


References
1.
Yeaman M, Norman D, Bayer A . Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother. 1992; 36(8):1665-70. PMC: 192027. DOI: 10.1128/AAC.36.8.1665. View

2.
Dhawan V, Bayer A, Yeaman M . Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother. 2000; 44(11):3206-9. PMC: 101635. DOI: 10.1128/AAC.44.11.3206-3209.2000. View

3.
Sullam P, Frank U, Yeaman M, Tauber M, Bayer A, Chambers H . Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis. 1993; 168(4):910-4. DOI: 10.1093/infdis/168.4.910. View

4.
Yan H, Hancock R . Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother. 2001; 45(5):1558-60. PMC: 90506. DOI: 10.1128/AAC.45.5.1558-1560.2001. View

5.
Xiong Y, Bayer A, Yeaman M . Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins. J Infect Dis. 2002; 185(3):348-56. DOI: 10.1086/338514. View